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Abstract: 
Synthetic pyrethroids are pesticides derived from naturally occurring pyrethrins, 
taken from pyrethrum of dried Chrysanthemum flowers. Pyrethroid insecticides are 
one of the most commonly used residential and agricultural insecticides. Many 
pyrethroids can significantly harm the nervous system. Permethrin could be one of 
the factors involved in the onset of neurodegenerative diseases.  The present study 
aims to evaluate in brain, the effect that can induce the exposure to permethrin, 
during early life of female rats (from 6 to 21 days of life). Therefore, have been 
examined the concentrations of permethrin and its main metabolite (3-PBA) in the 
brain and urine in female rats sacrificed the day after and 14 days after treating. The 
different concentrations of permethrin and 3-PBA (after 24h and after 14 days in the 
end of treatment) were obtained using two different methods. The evaluation of 
permethrin by liquid-liquid extraction and GC-ECD was performed. The levels of the 
3-PBA (in urine and brains) were obtained by SPE procedure and GC-MS using the 2-
PBA as internal standard. 
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1. Pyrethroids and Permethrin  
Synthetic pyrethroids such as, cypermethrin, deltamethrin, permethrin and 
cyfluthrin originate from the botanical insecticide pyrethrum, an extract obtained 
from the flowers of Chrysanthemum cinerariaefolium. Pyrethrins as one of the 
natural esters of pyrethrum and the synthetic pyrethroids are among the 
insecticides most often used worldwide (1). Pyrethrins, a single pesticide active 
ingredient, contain six components that have insecticidal activity: pyrethrin I, 
pyrethrin II, cinerin I, cinerin II, jasmolin I and jasmolin II (Figure 1).  
 
 
Figure 1: Structures of the six natural pyrethrins. 
 
The insecticidal properties of pyrethrins are derived from ketoalcoholic esters of 
chrysanthemic and pyrethroic acids. These acids are strongly lipophilic and rapidly 
penetrate many insects and paralyze their nervous system (2). Both pyrethrins and 
synthetic pyrethroids are sold as commercial pesticides used to control pest insects 
in agriculture, homes, communities, restaurants, hospitals, schools, and as a topical 
head lice treatment. Various formulations of these pesticides are often combined 
with other chemicals, known as synergists, to increase potency and persistence in 
the environment. Formulations that are commercially available include aerosols, 
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dips, emulsifiable concentrates, wettable powders, granules, and concentrates for 
ultra-low volume applications targeting mosquitoes. While chemically and 
toxicologically similar, pyrethrins are extremely sensitive to light, heat and moisture. 
In direct sunlight, half-lives that can be measured in hours. However, the 
pyrethroids, the synthetic analogues of naturally occurring pesticides, were 
developed to capture the effective insecticidal activity of this botanical insecticide, 
with increased stability in light, yielding longer residence times (3). Pyrethroids have 
replaced organophosphorus and carbamate insecticides because of their low toxicity 
toward mammals and high insecticidal activity. 
Permethrin was the first synthetic pyrethroids photostable enough to be used in 
agriculture and the most used pyrethroids in USA. Permethrin is an insecticide in the 
pyrethroids chemical family (Figure 2).                                                                    
 
 
Figure 2- Permethrin structure  
 
Permethrin was synthesized by replacing the methyl groups with chlorine atoms in 
the acid side-chain, which block photochemical degradation on the adjacent double 
bond. Permethrin has 4 isomers; the trans-isomer degrades more rapidly than the 
toxic cis-isomer and they have a lower toxicity in rats than do the corresponding cis-
isomers (Figure 3). 
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Figure 3:  Isomers of permethrin 
Permethrin is used as an insecticide or as an insect repellent or insect screen 
 in agriculture, to protect crops 
 in agriculture, to kill livestock parasites 
 for industrial/domestic insect control 
 in timber treatment 
 as a personal protective measure (cloth impregnant, used primarily for US 
military uniforms and mosquito nets) 
 in pet flea preventative collars or treatment 
Formulations of Permethrin are considered pharmaceuticals, which are regulated by 
the United States Food and Drug Administration (FDA) (4). Permethrin comes in 
many forms: sprays, dusts, fogs, emulsifiable concentrates and creams. Like all the 
pyrethroids, the permethrin belong to a group of chemicals that are neurotoxic and 
share a similar mode of action that is distinctive from other classes of insecticides. 
There are several ways that the permethrin can enter the body of an organism to 
exert their effects. The first mode is non-stereospecific with rapid penetration 
through the epidermis, followed by uptake by the blood or hemolymph carrier 
proteins and subsequent distribution throughout the body. Pyrethroid diffusion 
along the epidermis cells is the main route of distribution to the central nervous 
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system (CNS) after penetration (5). Pyrethroids also can enter the CNS directly via 
contact with sensory organs of the peripheral nervous system. The sensory 
structures of both invertebrates and vertebrates are sensitive to pyrethroids (6). 
Pyrethroids can also enter the body through the airway in the vapour phase, but 
such penetration represents only a small contribution due to the low vapour 
pressure of pyrethroids. Pyrethroids can also be ingested, and penetration into the 
blood-hemolymph through the alimentary canal can play an important role in 
toxicity. Because these insecticides are relatively non-volatile, the primary source of 
exposure is believed to be through diet. Additional exposure via ingestion of 
contaminated household dust may occur after the indoor application of pesticides 
such as Permethrin that is the main Pyrethroids used in the home for indoor pest 
control, in pet shampoos and treatment for wood furniture (7).  
 
1.1. Mode of action of pyrethroids: 
Pyrethroids have been classified toxicologically into two subclasses based on the 
induction of either whole body tremors (T syndrome) or a coarse whole body tremor 
progressing to sinuous writhing (choreoathetosis) with salivation (CS syndrome) 
following near-lethal dose levels in both rats (Rattus norvegicus) and mice (Mus 
musculus), and closely follows the chemical structure of the two types of 
pyrethroids (8,9). Type I pyrethroids (Pyrethroids lack a cyano group at the “carbon 
of the 3-phenoxybenzyl alcohol moiety”) are characterized by the T -syndrome 
which consists of aggressive sparring, sensitivity to external stimuli, fine tremors 
progressing to whole body tremors and prostration. Type I pyrethroids also elevate 
core body temperature, which is attributed to the excessive muscular activity 
associated with tremors. Type II pyrethroids (pyrethroids have a cyano group at the 
“carbon of the 3-phenoxybenzyl alcohol moiety”) are characterized by the CS 
syndrome which is comprised initially of pawing and burrowing behaviour followed 
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by profuse salivation, choreoathetosis, increased startle response, and terminal 
chronic seizures. Type II pyrethroids decrease core body temperature, which is 
attributed to excessive salivation and wetting of the ventral body surface. There are 
a few pyrethroids that produce mixed signs, including both tremors and salivation, 
and these are classified accordingly as type I/II (10). 
Multiple lines of evidence show that pyrethroids, as a class, do not act in a similar 
fashion on the voltage-gated sodium channels, and the classifications of toxicology 
are not absolute for either invertebrates or vertebrates (11, 12). Increasing the dose 
levels of pyrethrins and pyrethroids results in a proportional increase in motor 
activity, which is the classic dose-response effect with respect to neurotoxic 
substances. Pyrethroids and permethrin act very quickly to produce symptoms of 
lost coordination and paralysis which are known as "the knockdown effect", and 
which are often accompanied by spasms and tremors that induce intense repetitive 
activation in sense organs and in myelinated nerve fibres. The spasms can be violent 
and can cause the loss of extremities, such as legs and wings in insects. Physiological 
and biochemical studies, of pyrethroids show that in both vertebrates and 
invertebrates the primary mode of action is the binding of the voltage-gated sodium 
channel (6, 12-13). Mammals, unlike insects, however, have multiple iso-forms of 
the sodium channel that vary by tissue type, as well as biophysical and (14) 
pharmacological properties. Type I pyrethroids modify the sodium channels such 
that there is a slight prolongation of the open time, which results in multiple long 
action potentials. Type II pyrethroids significantly prolong channel open time, 
resulting in an increased resting membrane potential and often inducing a 
depolarization-dependent block of action potentials. Type I pyrethroids cause 
multiple spike discharges, while type II pyrethroids cause a stimulus-dependent 
depolarization of the membrane potential which reduces the amplitude of the 
action potential, and a loss of electrical excitability in both vertebrates and 
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invertebrates (6, 15). The toxic action is exerted by preventing the deactivation or 
closing of the gate after activation and membrane depolarization. This results in 
destabilizing the negative after potential of the nerve due to the leakage of Na+ ions 
through the nerve membrane. This causes hyperactivity by delaying the closing 
sodium channels which allows a persistent inward current to flow after the action 
potential, causing repetitive discharges that can occur either spontaneously or after 
a single stimulus. The differences between type I and II pyrethroids are expressed in 
the motor nerve terminals, where type I cause presynaptic repetitive discharges, 
and type II cause a tonic release of transmitter indicative of membrane 
depolarization (16, 17). Type II pyrethroids are a more potent toxicant than type I in 
depolarizing the nerves (17). Type II pyrethroids are associated with faster 
activation-deactivation kinetics on the Na+ sodium channels than type I pyrethroids 
in vertebrates (12). The higher toxicity of type II pyrethroids is mostly attributed to 
the hyper-excitatory effect on the axons which results from their stronger 
membrane depolarizing action. Type I pyrethroids modify the sodium channels in 
the closed state, while type II pyrethroids modify the open but not inactivated 
sodium channels (18). However, this relationship does not always hold true; for 
example the cis-permethrin interact with both closed and open sodium channels, 
but bind with greater affinity to the open state (19-21) (Figure 4) 
 
Figure 4- Pyrethroid effects on neuronal excitability. 
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Pyrethroids affect the voltage-sensitive calcium channels, y-aminobutyric acid 
(GABA) receptors and GABA-activated channels, and voltage-sensitive chloride 
channel (22, 23). Type II pyrethroids are more potent enhancers of Ca2+ influx and 
glutamate release under depolarizing conditions than type I pyrethroids (11, 19). 
The GABA receptor-chloride ionophore complex is also a target of type II 
pyrethroids. GABA is an inhibitory transmitter in the synapse of the CNS of both 
vertebrates and invertebrates. Pyrethroids inhibit the Ca-ATPase, Ca-Mg ATPase 
neurotransmitters and the peripheral benzodiazepine receptors, (24) but their 
action on these sites is minor compared with the voltage-gated sodium channels. 
The effects on these (22) sites could, however, enhance the uncontrolled 
convulsions and tremors. These changes in synaptic transmission may alter neuronal 
function and may contribute to toxicity and neurodegenerative pathology (24). 
  
1.2. Health effect and toxicity of permethrin  
The environmental presence of this pesticide as well as of other insecticides and 
fungicides has been correlated with neurological disorders such as Alzheimer’s 
disease, Parkinson’s disease or dementia in old age (25). Furthermore previous 
studies showed that Permethrin treatment in rats induced oxidative stress, immune 
system imbalance, cardiac and neuronal damage and cognitive deficits (16). The 
LD50 (the lethal dose that kills 50% of a population of test animals) for Permethrin is 
variable, ranging from 430 mg/kg body weight to over 4000 mg/kg for rats (26). 
Permethrin induces neurotoxicity, mutagenicity, cancer, immune system effects, 
cardiac toxicity and other effects. At relatively high doses, neurotoxic symptoms in 
mammals include tremors, loss of coordination, hyperactivity and an increase in 
body temperature (26). Permethrin leads to neuronal cell death in various parts of 
the brain, which could lead to motor deficits, learning and memory dysfunction. 
Ingestion of even small doses of Permethrin reduces the ability of immune system 
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cells to recognize and respond to foreign proteins. Doses equivalent to 1/100 of the 
LD50 inhibited T-Lymphocytes and Natural Killer (NK) cells by over 40% (27). 
Permethrin affects both male and female reproductive systems too; it binds to 
receptors for androgen (28). Permethrin was found to have mutagenic effects; in the 
human cell cultures, and caused an increase in chromosome aberrations, 
chromosome fragments and DNA lesions (26). Moreover, the World Health 
Organization (WHO) reported that permethrin increased the frequency of lung 
tumors in female mice, increasing the expression of a gene involved with the 
proliferation of cells in mammary gland (29). Permethrin was shown to increase the 
risk of prostate cancer in men with a family history of prostate cancer (30). 
 
1.3. Brain toxicity: 
Epidemiologic evidence suggests that environmental factors are an important cause 
of neurodegenerative diseases and psychiatric disorders (31). Contaminants 
accumulated through the food chain and environmental exposure can modify gene 
expression changing protein synthesis in different tissues (32). Pesticides are 
identified as one of the risk factors involved, through epigenetic mechanisms, in the 
regulatory processes controlling gene expression leading to the initiation and 
progression of age-related diseases (32). Even low levels of pesticides may 
negatively affect the brain inducing loss of neurons that leads to cognitive decline, 
impaired memory and attention, and motor function (31).These neuro behavioral 
disturbances may be associated with neurological disorders such as Alzheimer's 
disease, Parkinson's disease or dementia in old age (31). Permethrin is able to 
induce impairment of striatal mitochondrial function, changes in the immune 
system and oxidative stress in adult rats treated sub-chronically with a low dose of 
this pesticide (33). This pesticide could be one of the factors involved in the onset of 
neurodegenerative diseases, the results are discussed considering the variations in 
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the levels of neurodegenerative markers in cerebral areas, in plasma and in 
leukocytes. A developing brain is much more susceptible to the toxic effects of 
chemicals than an adult brain. This vulnerability period extends from fetal 
development through infancy, childhood and adolescence. The biological effects of 
pyrethroids are in part caused by their ability to alter neuronal activity since they 
interact with specific binding sites of voltage-gated sodium channel (VGSC) (VGSCs 
are the primary molecular targets for pyrethroids insecticidal activity and their acute 
neurotoxicity in vertebrates) (34) slowing the rate of VGSC closing, prolonging the 
inward sodium conductance and then shifting the membrane to more polarized 
potentials (35). A secondary consequence to cell membrane depolarization is an 
increased Ca2+ influx into the neurons through voltage-gated calcium channel 
(VGCC) that contributes to impact neuronal synaptic plasticity of neurons. Lower 
Dopamine (DA) levels and accelerated DA turnover following early life permethrin 
treatment was also observed (35). Midbrain dopamine (DA) neurons are formed in 
the ventral tegmentum during development. DA cells have been extensively studied, 
mostly because of their critical involvement in disorders such as Parkinson’s disease 
and schizophrenia. The pesticides may negatively affect the brain inducing loss of 
neurons that leads to cognitive decline, impaired memory and attention, and motor 
function (35). Recently, showed that when permethrin was administered during 
early life (from 6th to 21st day), alterations in striatum (36), in heart and in plasma 
(37), were observed during adult age. The dopamine turnover and oxidative stress 
measured in adult rats treated with a low dose of permethrin during early life (1/50 
LD50, from 6th to 21st day of life) (35), can be associated with other signs 
characteristic of neurological disorders. With this aim, the levels of Nurr1, a 
transcription factor essential for the maintenance of dopaminergic neurons, and 
other markers correlated with neurodegeneration such as glutamate, calcium, nitric 
oxide (NO), superoxide dismutase (SOD) were evaluated. Some results show that 
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early life permethrin treatment reduces Nurr1 mRNA and protein expression as well 
as calcium and NO levels in striatum from adult rats. An imbalance in glutamate, 
calcium and NO levels was measured in hippocampus from treated rats, while no 
changes in prefrontal cortex were detected. Calcium levels measured in leukocytes 
from treated rats resulted decreased, as well as calcium and SOD in plasma, in which 
increased NO levels were found. The hypothesize is that the intake of this pesticide 
could be one of the factors involved in the onset of neurodegenerative diseases, the 
results are discussed considering the variations in the levels of neurodegenerative 
markers in cerebral areas, in plasma and in leukocytes. Nurr1 was chosen because it 
is a nuclear transcription factor regulating the development and maintenance of 
dopaminergic neurons, in limbic areas, in the ventral DA neurons, and in cortical 
areas, where its distribution overlaps with DA containing neurons (38). It is 
important for neuronal plasticity and has been reported decreased in PD as well as 
modified in other neuronal disorders (39). Nurr1 can modulate the NF-kB ("nuclear 
factor kappa-light-chain-enhancer of activated B cells") activity in brain microglia, 
and since the effect of permethrin treatment can trigger an oxidative stress 
imbalance on redox systems (40), NF-kB and Nrf2(NF-E2-related factor 2), two of the 
main transcription factors regulating the genes involved in pro-inflammatory and 
anti-inflammatory responses respectively, were studied. Moreover NF-kB is even 
modulated by calcium; in fact this element is a common second messenger whose 
concentration within a cell is finely modulated to promote many physiological 
functions as hormonal release, muscular contraction, and gene expression (41). 
Calcium is linked with membrane polarization and therefore related with neuronal 
homeostasis and brain senescence (42). In neurons the calcium channels function is 
depending on their position, at presynaptic level, they modulate the 
neurotransmitters release, while at post-synaptic level they can modulate learning 
and memory processes (43), in fact an increase in the luminal level of calcium is 
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correlated with the learning and memory deficits that occur during the onset of 
Alzheimer disease (43). Moreover, together with the up regulation of dopamine 
synthesis and the presence of α-synuclein aggregates, high cytoplasmic Ca2+ levels 
led to selective death of substantia nigra dopaminergic neurons, causing the typical 
motor deficits of Parkinson’s disease. Neurotransmitters as glutamate induce an 
influx of calcium by receptor-operated channels such as NMDA receptors (N-methyl-
D-aspartate receptor) at post-synaptic sites (43) where an abnormal release of 
glutamate causes their over-activation that occurs in excessive accumulation of 
intracellular calcium. NMDA receptor anchored to NO synthase modulate the 
production of nitric oxide (NO), a neural modulator involved in neurotransmitters 
release, neuronal excitability, learning and memory (44). Therefore nitric oxide 
overproduction due to glutamate triggered toxicity, together with the NO released 
by astrocytes and microglia with response to inflammatory stimuli, contribute to the 
oxidative damage reported in post mortem studies, in vitro and in vivo Parkinson’s 
disease models (45) and also in the neuropathology of Alzheimer disease (46). 
 
2. Permethrin kinetics  
2.1. Absorption: 
Absorption of pyrethroids through the gastrointestinal tract and the skin is variable 
and depends on the vehicle of administration. For the general population the main 
route of exposure to agricultural pesticides is through residues in food, studies 
carried out on workers suggest that, similarly to any other pesticide, dermal 
exposure is the most significant route of absorption for agricultural applicators and 
sprayers in fact minimally it is absorbed through intact skin (studies involving skin 
applications of Permethrin indicated that about 0.5% of the applied dose was 
absorbed dermally) (47). However the penetration of pyrethroids into the skin is 
slow and may cause a typical local paraesthesia (tingling and burning sensations), 
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which may persist for several hours. Can be absorbed even from the 
gastrointestinal tract and by inhalation of dust and spray mist. Animal studies 
showed quick and substantial absorption of Permethrin upon ingestion (48). In one 
study of rats, about 60% of the orally administered dose was absorbed with an 
absorption half-life of less than one hour (49). 
 
2.2 Distribution:  
After absorption, pyrethroids are rapidly distributed throughout the body, mainly in 
the adipose tissue, stomach, intestine, liver and kidneys and the nervous system. 
Peak concentrations measured in plasma, nerve tissue, liver, and kidneys occurred 
around four hours after ingestion. Levels found in nervous tissues were generally 
higher compared with in plasma (50). A human case study involving an intentional 
ingestion of Permethrin showed a similar distribution pattern with a peak 
Permethrin concentration found in blood three to four hours after ingestion (51).  
 
2.3. Metabolism: 
Several studies done using rats, goats, cows, and hens, have demonstrated that the 
Permethrin were metabolized quickly in the liver. Hydrolysis, hydroxylation, 
oxidation, and conjugation are all involved in the process of metabolism (48) (52). 
Permethrin itself is considered the only compound of toxicological significance (48) 
(53) even if were identified several metabolites of permethrin. Permethrin is easily 
hydrolysed, and the hydrolysis product is also easily oxidized in rats in vitro. 
Permethrin is converted to PBAlc (3-Phenoxybenzyl alcohol) and further to PBAld 
(3-phenoxybenzylaldehyde) and 3-phenoxybenzoic acid (3-PBA) by mixed function 
oxidase in rats. Trans-isomers are more rapidly metabolized by hydrolytic (esterase) 
pathways while cis-isomers are preferentially metabolized by slower oxidative 
(P450) pathways (50). The cis-isomer of permethrin, which is metabolized 
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predominantly by P450’s in laboratory animals (50), was not detectably 
metabolized in human liver microsomes in the presence or absence of an NADPH 
regenerating system (52). Oxidations of PBAlc and PBAld are mainly mediated by 
mixed function oxidase, in addition to ADH (alcohol dehydrogenase) and ALDH 
(aldehyde dehydrogenase), which were shown to contribute to the oxidation by 
Hodson and co-workers (2002; 2003). The alcohol generated from permethrin, 
PBAlc is oxidized to PBAld, and the aldehyde is further oxidized to 3-PBA by rat liver 
microsomes. The alcohol and aldehyde moieties of pyrethroids are mainly 
metabolized by oxidation to the corresponding aldehydes and carboxylic acids by 
ADH and ALDH in mammalian species (52). The terminal phase of pyrethroids 
metabolism is the formation of glucuronide and glycine conjugates (54). These 
pathways appear similar between laboratory animals and humans. Common 
metabolites are found in the urine of both laboratory animals and humans (53, 54). 
The 3-PBA metabolite is common to 10 of the 18 pyrethroids registered in the 
United States, including permethrin, cypermethrin, deltamethrin, esfenvalerate 
(55). Both type I and type II pyrethroids undergo ester hydrolysis which results in a 
cyclopropyl acid and either 3-phenoxybenzyl alcohol (type I) or a cyanohydrin (type 
II) (56). The aromatic alcohol is further oxidized to 3-PBA while the cyanohydrin is 
able to spontaneously rearrange to the phenoxybenzaldehyde in aqueous solutions 
and then undergo hydroxylation to 3-PBA. 3-PBA is a nonspecific urinary 
metabolite, meaning that it is a breakdown product common to most of the 
pyrethroids with the exception of cyfluthrin. It is also the most frequently detected 
urinary metabolite in humans (Figure 5). Since 3-PBA is a common metabolite for 
most pyrethroids pesticides, it has been used as a marker of pyrethroids exposure 
by the Center for Disease Control and Prevention in the National Health and 
Nutrition Examination Survey study (57). The elimination half-life of about 8 h 
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reported for 3-PBA among workers exposed to cypermethrin (58) suggests that 88% 
of the metabolite is excreted within the first 24 h following exposure. 
 
Figure 5: Metabolic clearance of permethrin [1RS, 3RS:1RS, 3RS (cis: trans)], 
cypermethrin [RS- α-cyano; 1RS, 3RS; 1RS, 3SR (cis: trans)], or deltamethrin-[1R; cis; 
alpha S]. Oxidation via cytochrome P450 yields hydroxyl derivatives (a) of the 
parent compound (e.g., 4-hydroxy permethrin). Hydrolysis (c), via 
carboxylesterases, yields a dichlorovinyl acid (permethrin, cypermethrin) or 
dibromovinyl acid (deltamethrin) and phenoxybenzyl alcohol. An important 
pathway for urinary metabolite of cis isomers oxidation leads to ester cleavage 
products following hydroxylation at the carbon proximal to the ester (b). 
 
2.4. Excretion: 
Permethrin and its metabolites are excreted primarily in the urine, but also in the 
feces (48, 59). In rats given oral doses of permethrin, the excretion half-life was 
measured at 12.3 hours for plasma and from 9 to 23 hours for brain and nervous 
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tissue, including the medulla oblongata (60). 3-PBA is the main metabolite of the 
permethrin and other pyrethroids resulting from the oxidation of the 3-
phenoxybenzyl alcohol. Its concentration in the urine is the most representative 
marker for pyrethroids exposure in rodents (61) and humans (62). 
 
3. Materials and methods 
3.1. SPE (Solid-phase extraction) Method Development  
Extraction methods: 
Solid-phase extraction (SPE) is an extraction method that uses a solid phase and a 
liquid phase to isolate one, or one type, of analyte from a solution. It is usually used 
to clean up a sample before using a chromatographic or other analytical method to 
quantitate the amount of analyte(s) in the sample. It is a fast method, easy to 
handle for analysis in a variety of domains:  
The common SPE applications are:  
• Pharmaceutical compounds and metabolites in biological fluids; 
• Drugs of abuse in biological fluids;  
• Environmental pollutants in drinking and waste water; 
• Pesticides and antibiotics in food/agricultural matrices; 
• Desalting of proteins and peptides; 
• Fractionation of lipids; 
• Water and fat soluble vitamins 
The SPE process basically consists in four different steps: conditioning, sample 
addition, washing and elution (63) (Figure 6). 
In general, SPE can be used for three important purposes in up-to-date analyses: 
• Concentration of the analyte; 
• Removal of interfering substances; 
• Changing the matrix of the analyte as needed for subsequent analyses 
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In most cases these three effects occur together.  
SPE uses the affinity of solutes dissolved or suspended in a liquid (known as the 
mobile phase) for a solid through which the sample is passed (known as the 
stationary phase) to separate a mixture into desired and undesired components. 
The result is that either the desired analytes of interest or undesired impurities in 
the sample are retained on the stationary phase. The portion that passes through 
the stationary phase is collected or discarded, depending on whether it contains the 
desired analytes or undesired impurities. If the portion retained on the stationary 
phase includes the desired analytes, they can then be removed from the stationary 
phase for collection in an additional step, in which the stationary phase is rinsed 
with an appropriate eluent.  
 
Figure 6: Representation of SPE clean-up procedure 
The stationary phase comes normally in the form of a packed syringe-shaped 
cartridge of which can be mounted on its specific type of extraction manifold. The 
manifold allows multiple samples to be processed by holding several SPE media in 
place and allowing for an equal number of samples to pass through them 
simultaneously. Most SPE manifolds are equipped with a vacuum port. Application 
of vacuum speeds up the extraction process by pulling the liquid sample through the 
stationary phase. The analytes are collected in sample tubes inside or below the 
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manifold after they pass through the stationary phase. Solid phase extraction 
cartridges and disks are available with a variety of stationary phases, each of which 
can separate analytes according to different chemical properties. Most stationary 
phases are based on silica that has been bonded to a specific functional group. 
Sorbent selection requires consideration of sample volume, the nature of the 
analyte, analyte concentration and the inherent properties of the sorbent itself. 
Silica and polymers are the most popular sorbents used for SPE. Polymer loading 
capacities are higher than silica sorbents; however, silica sorbents exhibit greater 
selectivity. During the drying step, the risk of oxidation of the analytes could be 
minimized by the addition of anti-oxidant agents, such as ascorbic acid (64). In 
addition, sodium chloride (NaCl) can be added to the sample to improve the 
extraction efficiency (65). SPE cartridges should not be allowed to dry at any point 
during conditioning and sample loading, in order to keep the sorbent ligands active 
and prevent air from trapping in the cartridges. A comparison between automated 
SPE-GC-ECD with non-automated SPE-GC-ECD in the extraction of some pyrethroids 
from surface water showed that automated SPE could be used successfully for 
extraction and pre-concentration of pesticides (66). 
 
3.1.1. Normal Phase SPE procedure (Non-polar Sample Matrix) 
A typical solid phase extraction involves four basic steps. First, the cartridge is 
equilibrated with a non-polar solvent or slightly polar, which wets the surface and 
penetrates the bonded phase. Then water, or buffer of the same composition as 
the sample, is typically washed through the column to wet the silica surface. The 
sample is then added to the cartridge. As the sample passes through the stationary 
phase, the analytes in the sample will interact and retain on the sorbent while the 
solvent, salts, and other impurities pass through the cartridge. After the sample is 
loaded, the cartridge is washed with buffer or solvent ton remove further 
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impurities. Then, the analyte is eluted with a non-polar solvent or a buffer of the 
appropriate pH. A stationary phase of polar functionally bonded silicas with short 
carbons chains frequently makes up the solid phase. This stationary phase will 
adsorb polar molecules which can be collected with a more polar solvent (67). 
3.1.2.  Reversed phase SPE (Aqueous Sample Matrix) 
Reversed phase SPE separates analytes based on their polarity. The stationary 
phase of a reversed phase SPE cartridge is derivatized with hydrocarbon chains, 
which retain compounds of mid to low polarity due to the hydrophobic effect. The 
analyte can be eluted by washing the cartridge with a non-polar solvent, which 
disrupts the interaction of the analyte and the stationary phase (67). A stationary 
phase of silicon with carbon chains is commonly used. Relying on mainly non-polar, 
hydrophobic interactions, only non-polar or very weakly polar compounds will 
adsorb to the surface (67). 
 
3.1.3.  Cation Exchange  
Cation exchange sorbents are derivatized with functional groups that interact and 
retain positively charged cations, such as bases. Strong cation exchange sorbents 
contain aliphatic sulfonic acid groups that are always negatively charged in aqueous 
solution, and weak cation exchange sorbents contain aliphatic carboxylic acids, 
which are charged when the pH is above about 5. Strong cation exchange sorbents 
are useful because any strongly basic impurities in the sample will bind to the 
sorbent and usually will not be eluted with the analyte of interest; to recover a 
strong base a weak cation exchange cartridge should be used. To elute the analyte 
from either the strong or weak sorbent, the stationary phase is washed with a 
solvent that neutralizes ionic interaction between the analyte and the stationary 
phase (67). 
For this study was used: 
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Selectivity: strata™-X-C Strong Cation Exchange and Reversed Phase (Figure 7)  
 
Figure 7: Functional group of cartridge   
 Particle size       (μm) 33 
 Pore size           (Å) 85 
 Surface area     (m2 /g) 800 
 pH stability       1-14 
 Ionic capacity  1 meq/g 
Cleaner Reproducible Extractions:  
Unlike traditional silica-based mixed mode sorbents that are blended, strata-X-C 
has a strong cation exchange group uniformly bonded on the polymeric surface 
completely eliminating recovery or reproducibility problems. The strong cation 
exchange mechanism gives consistent and extremely clean extracts from biologi- 
cal matrices such as plasma and urine since hydrophobic contaminants can be 
completely removed by using 100 % organic wash solvents. 
 
3.2. Gas Chromatography 
Gas Chromatography (GC or GLC) is a commonly used analytic technique in many 
research and industrial laboratories for quality control as well as identification and 
quantitation of compounds in a mixture. GC is also a frequently used technique in 
many environmental and forensic laboratories because it allows for the detection 
of very small quantities. A broad variety of samples can be analysed as long as the 
compounds are sufficiently thermally stable and volatile. A mobile and a stationary 
phase are required for this technique. The mobile phase (=carrier gas) is comprised 
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of an inert gas i.e., helium, argon, or nitrogen. The stationary phase consists of a 
packed column where the packing or solid support itself acts as stationary phase, or 
is coated with the liquid stationary phase (=high boiling polymer). Most analytical 
gas chromatographs use capillary columns, where the stationary phase coats the 
walls of a small-diameter tube directly (i.e., 0.25 µm film in a 0.32 mm tube). The 
separation of compounds is based on the different strengths of interaction of the 
compounds with the stationary phase (“like-dissolves-like”-rule). The stronger the 
interaction is, the longer the compound interacts with the stationary phase and 
more time it takes to migrate through the column (=longer retention time). 
The factors which influence the separation of the components are: 
Boiling point: 
The boiling point of a compound is often related to its polarity. The lower the 
boiling point is, the shorter is the retention time because the compound will spent 
more time in the gas phase. That is one of the main reasons why low boiling 
solvents (i.e., diethyl ether, dichloromethane) are used as solvents to dissolve the 
sample. The temperature of the column does not have to be above the boiling 
point because every compound has a non-zero vapour pressure at any given 
temperature.  
The polarity of components versus the polarity of stationary phase on column: 
If the polarity of the stationary phase and compound are similar, the retention time 
increases because the compound interacts stronger with the stationary phase. As a 
result, polar compounds have long retention times on polar stationary phases and 
shorter retention times on non-polar columns using the same temperature. 
Column temperature: 
An excessively high column temperature results in very short retention time but 
also in a very poor separation because all components mainly stay in the gas phase. 
If the compound does not interact with the stationary phase, the retention time 
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will decrease. At the same time, the quality of the separation deteriorates, because 
the differences in retention times are not as pronounced anymore.  
Carrier gas flow rate: 
A high flow rate reduces retention times, but a poor separation would be observed 
as well. Like above, the components have very little time to interact with the 
stationary phase and are just being pushed through the column. 
Column length: 
A longer column generally improves the separation. The trade-off is that the 
retention time increases proportionally to the column length and a significant peak 
broadening will be observed as well because of increased longitudinal diffusion 
inside the column.  
Amount of material injected: 
Ideally, the peaks in the chromatogram display a symmetric shape (Gaussian curve). 
If too much of the sample is injected, the peaks show a significant tailing, which 
causes a poorer separation. Most detectors are relatively sensitive and do not need 
a lot of material in order to produce a detectable signal.  
 
3.2.1. GC-MS (Gas chromatography mass spectrometry) 
Gas chromatography mass spectrometry (GC/MS) is an instrumental technique, 
comprising a gas chromatograph (GC) coupled to a mass spectrometer (MS), by 
which complex mixtures of chemicals may be separated, identified and quantified. 
This makes it ideal for the analysis of the hundreds of relatively low molecular 
weight compounds found in environmental materials. In order for a compound to 
be analysed by GC/MS it must be sufficiently volatile and thermally stable. In 
addition, functionalised compounds may require chemical modification 
(derivatization), prior to analysis, to eliminate undesirable adsorption effects that 
would otherwise affect the quality of the data obtained. Samples are usually 
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analysed as organic solutions consequently materials of interest (e.g. soils, 
sediments, tissues etc.) need to be solvent extracted and the extract subjected to a 
clean-up before GC/MS analysis is possible. The sample solution is injected into the 
GC inlet where it is vaporized and swept into a chromatographic column by the 
carrier gas (usually helium). The sample flows through the column and the 
compounds comprising the mixture of interest are separated by virtue of their 
relative interaction with the coating of the column (stationary phase) and the 
carrier gas (mobile phase). The latter part of the column passes through a heated 
transfer line and ends at the entrance to ion source where compounds eluting from 
the column are converted to ions. The next component is a mass analyser (filter), 
which separates the positively charged ions according to various mass related 
properties depending upon the analyser used. After the ions are separated they 
enter a detector the output from which is amplified to boost the signal. The 
detector sends information to a computer that records all of the data produced, 
converts the electrical impulses into visual displays and hard copy displays. In 
addition, the computer also controls the operation of the mass spectrometer. 
 
3.2.2. GC-ECD (Gas chromatography Electron capture detectors) 
Electron capture detectors (ECD) are typically used in environmental testing for 
detecting PCB’s, organochlorine pesticides, herbicides and various halogenated 
hydrocarbons. ECD consists of a cavity that contains two electrodes and a radiation 
source that emits –radiation. The collision between electrons and the carrier gas 
(methane plus an inert gas) produces a plasma-containing electrons and positive 
ions. If a compound is present that contains electronegative atoms, those electrons 
will be “captured” to form negative ions and the rate of electron collection will 
decrease. The detector is extremely selective for compounds with atoms of high 
electron affinity, but has a relatively small linear range. 
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4. Experimental Part 
4.1. Reagents  
The reagents used were:  
n-Hexane [ purity 99%], acetonitrile (ACN) [purity 99.9%] , magnesium sulphate 
(MgSO4 ), sodium acetate (CH3COONa), chloridic acid (HCl) [purity 36.5-38%], 
potassium hydroxide (KOH), ethyl acetate (CH2COOC2H5) [purity 99.8%], methanol 
(CH3OH), ammonium hydroxide (NH4OH) [purity 31.2%] pH 10, methanol 5% in 
ethyl acetate [ purity 99.5%], hexafluoro-2-propanol (HFEIP) [purity 99.8%] , N,N'-
Diisopropylcarbodiimide (DIC) [ purity 99%], potassium carbonate (K2CO3).  
 
4.2.  Sampling  
7 Female rats were treated with permethrin from 6 to 21 days of life. Then 4 of 
them were sacrificed the day after (22 days of life) and the other 3, 14 days after 
the treatment (35 days of life). Hearts and urine were collected (data of the 
collection 29/10/2013) from these rats.  
The samples were at -20°C until analysis, which were made at room temperature. 
 
4.3. Sample preparation 
In order to carry out this study, samples (rat's brain) have been homogenized with a 
drill by a Torax equipment and preserved in approximately 5mL of ACN at -20°C. In 
order to determinate the concentrations of 3-PBA, 2-PBA and permethrin, several 
tests were performed. 
 
4.4. Solution preparation 
12.09 mg of permethrin have been weighed in a 5 mL flacks.  
With this amount of permethrin were prepared: 
 Permethrin solution 1 (1209mg/L) 
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 Permethrin solution 2 (10mg/L) 
 Permethrin solution 3 (500µg/L) 
 Permethrin solution 4 (625µg/L) 
 Permethrin solution 5 (125µg/L)  
Preparation of microvials for calibration curve: 
 Two series of standards for calibration curve were prepared: 
 Concentrations: 0.3mg/L, 0.4mg/L, 0.6mg/L, 0.7mg/L, 0.8mg/L and 0.9mg/L; 
 Concentrations: 0.5mg/L; 0.4mg/L; 0.3mg/L; 0.2mg/L; 0.1mg/L; 0.05mg/L; 
0.02mg/L  
 Buffer solution pH7: 
  2.86mL of glacial acetic acid have been taken, put in a flask and diluted with 
H2O until 500mL (solution A) 
 One the other hand 6.8g of sodium acetate have been taken, put in a flask 
and diluted with H2O until 500mL (solution B) 
 The buffer solution has been prepared with 89.25 mL from solution A and 
160.75mL from solution B 
Moreover some solutions have been prepared with 3-PBA and with 2-PBA:  
 • 3-PBA solution 1: 2000mg/L,  
 • 3-PBA solution 2: 10mg/L 
 • 3-PBA solution 3: 50µg/L  
 • 3-PBA solution 4: 5 µg/L 
 • 3-PBA solution 5: 2 µg/L 
 • 2-PBA solution 1: 2000 mg/L 
 • 2-PBA solution 2: 10mg/L  
 • 2-PBA solution 3: 50µg/L 
 For 3PBA and 2PBA calibration curves were prepared:  
Concentrations 3PBA: 0.01µg/L, 0,05µg/L, 0,1µg/L, 0,3µg/L, 0,5µg/L, 1µg/L, 1,5µ/L 
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Concentration 2PBA; 20µg/L 
 
Ions selected for the identification of metabolites 3-PBA and 2-PBA are: 135:169; 
141; 195; 197. The most abundant ion for metabolite 3-PBA is 364 the most 
abundant ion for metabolite 2-PBA is 195. 
A NH4OH solution with pH 10 was prepared through the dilution of pure NH4OH. 
 
4.5. Procedure  
For preliminary studies only the buffer solution was used: 
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Figure 8: Scheme of procedure for preliminaries tests 
 
The solid phase extraction (SPE) consisted in: 
Conditioning:  
 5 mL of ethyl acetate 
 5 mL MeOH 
 5 mL H20 
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 5 mL of HCl 
Add sample  
 5 mL of sample 
Cleaning  
 5 mL of HCl 
 5 mL of NH4OH 
Drying 
Elution: 
 5 mL of 5% of MeOH in AcOEt 
 
Before injection in GC a derivatization was performed, the procedure is described in 
figure 9 
Derivatization reactions are meant to transform an analyte for detectability in Gas 
Chromatography (GC) or other instrumental analytical methods. Derivatization in GC 
analysis can be defined as a procedural technique that primarily modifies an 
analyte’s functionality in order to enable chromatographic separations. A modified 
analyte in this case will be the product, which is known as the derivative. The 
derivative may have similar or closely related structure, but not the same as the 
original non-modified chemical compound. Volatility of sample is a requirement for 
GC analysis. Derivatization will render highly polar materials to be sufficiently 
volatile so that they can be eluted at reasonable temperatures without thermal 
decomposition or molecular re-arrangement. 
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Figure 9: Scheme of derivatization procedure  
Several brains obtained from rats, not treated with permethrin, were used in order 
to standardize the method. The general procedure with brains is described in figure  
10 
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Figure 10: Scheme of procedure to standardized the method  
During the tests several changes have been carried to the method, namely:  
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 At first samples have been filtrated with paper filter in the beginning of test. 
Then the aqueous phase was filtrated in order to prevent a loss of 
permethrin. 
 The minutes of ultrasound were increased from 10’ to 20’ to have clear 
separation between the aqueous phase and supernatant. 
 The procedure of derivatization has been modified; 150 µL of n-hexane to 
improve the concentration of 3-PBA and 2-PBA.  
 
 
In other to verify the method, several tests were performed using the samples from 
rats treated with permethrin that are described in Figure 11 
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Figure 11: Scheme of procedure with sample from rats treatment with permethrin  
The permethrin, 3-PBA and 2-PBA -data from brains from treated rats were obtained 
with the procedure described in figure 12. 
A control with buffer and enzyme but without sample was performed. Only results 
with higher values than the achieved by the control was processed. 
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Figure 12: Scheme of procedure with rats treaded with permethrin 
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3-PBA values from urines were obtained with the procedure described in figure 13. 
 
Figure 13: Scheme of procedure with urines from rats treated with permethrin 
 
4.6. Chromatographic analysis 
Permethrin was analyzed using a Shimadzu GC-2010 with ECD apparatus equipped 
with a capillary column ZB-XLB (30 m x 0.25 mm x 0, 25 mm) from Phenomenox. A 
volume of injection 1µL was used. The oven temperature was programmed starting 
at 60°C and held for 1’min followed by increase of 30°C/min to 250°C and then 
increase 10°C/min until 290°C and held for 3’. The detection was 300°C C. Helium 
(Linde Sogas) was used as carrier gas at a constant flow rate of 1.3 mL/min, whereas 
nitrogen (Linde Sogas, purityg99.999%) was employed as makeup gas at a flow of 30 
mL/min. The system was operated by GCsolution Shimadzu software. 
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Operation of a GC/MS in SIM mode allows for detection of specific analytes with 
increased sensitivity relative to full scan mode. Because the instrument is set to look 
for only masses of interest it can be specific for a particular analyte of interest. 
Typically two to four ions are monitored per compound and the ratios of those ions 
will be unique to the analyte of interest. In order to increase sensitivity, the mass 
scan rate and dwell times.  
The equipment that has been used for testing these samples it was GC-MS/SIM and 
MS/MS using a Supelco column fitted with an SLB-5MS (30 m x 0.25 mm x 0.25µm 
film thikness) column operating in the splitless mode. Helium was used as carrier gas 
at a constant flow rate of 1.3 mL/min. The oven temperature was programmed 
starting at 40 C and held for 1 min, followed by increases of 15 C/min to 260. The ion 
source and MS transfer line were at 250°C. 
 
4.7. Recoveries evaluation 
The recoveries were achieved by the relation between the area of the analyt 
(permethrin or 3-PBA) after the procedure and the area of a standard analyt in 
solution. 
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5. Results and discussion: 
5.1. Chromatography results  
5.1.1. GC-ECD, retention time, linearity, calibration curve permethrin 
A solution containing permethrin was injected in GC-ECD and the retention time was 
recorded. Figure 14 show the chromatogram obtained with the peak of permethrin 
achieving 7.6 min of retention time.  
 
Figure 14: Chromatogram retention time permethrin 
It was injected in GC-ECD five standards of permethrin (0.3 µg/L; 0.4 µg/L; 0.6 
µg/L;0.8µg/L; 0.9 µg/L). Figure 15 shows the achieved calibration curve for 
Permethrin. It was observed linearity between 0.3 to 0.9 µg/L of permethrin in n-
hexane. A R2 higher than 0.9842 was achieved.  
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Figure 15: Calibration curve of permethrin achieved by the correlation of area versus 
concentration 
5.1.2. GC-MS retention time, linearity, calibration curve  
The retention time of 3-PBA was obtained by the injection in SIM mode of a 
derivatized solution.  
Figure 16 shows the chromatogram obtained with the respective spectrum. The 
achieved retention time of 2-PBA was 8.9 min. 
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Figure 16: Chromatogram showing the peak of 3-PBA and 2-PBA (11.52 min and 8.9 
min) and the spectra of 3-PBA 
 
In figure 17 is shown the calibration curve for 3-PBA. It was observed linearity 
between 0.01 to 1.5 µg/L of 3-PBA. A R2 higher then 0.9864was achieved. 
 
Figure 17: Calibration curve 3-PBA 
The average area obtained in all chromatograms with 20 µg/L was 497601.2. 
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6. Recoveries:  
The recoveries were obtained using the quotient between the area obtained with 
the tested procedure and the area obtained with a standard. The 3-PBA and 2-PBA 
recovery obtained with buffer solution was 78% and 58%, respectively. Identical 
procedure was performed with samples from rats not treated with permethrin in 
buffer solution. The recoveries of 3-PBA obtained with different tested procedures 
(ultrasounds 10’ and 20’) are shown in figure 18: 
 
 
Figure 18:  Recoveries of 3-PBA obtained in samples with different procedures 
The highest recovery is obtained with the procedure that uses 20 min in 
ultrasounds, achieving 66.9 % of recovery. 
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The recoveries of 2-PBA obtained with different procedures are shown in figure 19. 
 
Figure 19: Recoveries of 2-PBA obtained with different times in ultrasound 
 
For 2-PBA 10 min in ultrasounds is sufficiently to achieve 104 % of extraction. 
However for 3-PBA is necessary 20 min to achieve 67% of recovery, for that reason it 
was selected the procedure with 20 min in ultrasound. 
The amounts of permethrin and 3-PBA in brains from female rats treated with 
permethrin were obtained using the equations from the calibration curves. Figure 
20 shows the parallel between quantities of permethrin in brains of female rats 
treated with permethrin and sacrificed the day after the treatment (22 days of life) 
and brains of female rats treated with permethrin and sacrificed 14 days after the 
treatment (35 days of life). 
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Figure 20: Permethrin concentration in rats brains after 24h and 14 days of exposure 
The results demonstrate that permethrin was found in both brains of female rats 
sacrificed on the day after (24h after) and 14 days after the end of treatment. Such 
as the graph shows the concentration of permethrin in the brains from female rats 
sacrificed the day after the end of treatment is lower than that found in the brains 
of female rats sacrificed the 14th day after the end of treatment. The higher levels 
achieved in brains may be explained with the lipophilic character of this organ. 
Accordingly it can be affirm that the exposure to permethrin can represent a risk 
factor for the development of neuro- degenerative diseases. 
The data of the metabolite of permethrin in brain is show in figure 21. 
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Figure 21: Concentration of 3-PBA in brains after 24 h and after 14 days of exposure.  
These results show that in female rats sacrificed the day after (24h) the end of 
treatment, the amount of metabolite 3-PBA is high in contrast to the amount that 
was found in female rats sacrificed 14 days after the end of treatment. This results 
in agreement with other authors (58). The amount of 3-PBA 14 days after the end of 
the treatment is lower than the limit of detection because the area detected by the 
equipment was lower than that of the buffer. 
The amounts of 3-PBA in urines of female rats treated with permethrin were 
calculated using the equations of calibration curves. Figure 22 shows the quantities 
of 3-PBA in urines of rats sacrificed the days after and 14 days after the treatment 
with permethrin. 
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Figure 22: Concentration of 3-PBA in urines of rats 
Such as is possible to see from figure 21, 3-PBA was found both in urines of rats 
sacrificed after 24 hours and after 14 days of the end of treatment with permethrin. 
The concentration of 3-PBA in urines of rats sacrificed after 24 hours is almost 30 
times greater than the concentration of 3-PBA in urines of rats sacrificed after 14 
days of the end of treatment. These data are in agreement with others authors (58) 
that described that 88% of the 3-PBA is excreted within the first 24 h following 
exposure. 
 
 
 
 
 
 
 
43 
 
7. Conclusion:  
In this research, were studied female rats from the same treatment to investigate 
the effect of early life permethrin and its major metabolite on the brain. These 
results could confirms a neurodegenerative process associated with exposure to this 
pesticide, (Parkinson-like neurodegeneration). In all the brain samples treated with 
the same concentration the permethrin concentrations increase from 24h to 14 
days 13.5 times. The metabolite achieved a maximum level at 24 h (2.6 µg/L) and 
none of the samples of 14 days achieved values above the limit of detection.  
Therefore this results link the hypotheses that permethrin in the brain longer than 
expected. Accordingly it can be affirm that the exposure to permethrin can 
represent a risk factor for the development of neuro- degenerative diseases. 
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Calculations Permethrin solutions: 
C1*V1=C2*V2 
• Permethrin solution1= 12.090µg/10*10^-3 = 1209 mg/L 
• Permethrin solution 2 = 1209mg/L *V1= 10mg *5000µL 
V1= 41.36µL 
Then 41.36µL from the flask and have been taken and put in another 5 ml flask,after 
that  hexane has been added until the flask’s line of demarcation (5ml). 
• Permethrin solution 3= 10mg/L*V=0.5mg/L*1000µL 
Vm2= 50µL 
From the flask containing the mother solution 2, 50 µL have been taken and 
transferred then in microvial. Then hexane has been added until 1 ml. 
• Permethrin solution 4= 500µg/L*V=0.625 µg/L*5000 µL 
V= 6.25 µL 
6.25 µL from the flask and have been taken and put in another 5 ml flask,after that  
hexane has been added until the flask’s line of demarcation (5ml). 
• Permethrin solution 5: 0.625 µg/L*V= 0.125 µg/L*5000 µL 
V=1000 µL 
1000 µL from the flask and have been taken and put in another 5 mL flask, after that 
hexane has been added until the flask’s line of demarcation (5mL). 
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Permethrin calibration curve: 
Concentration Area 
0.3µg/L 404822 
0.4 µg/L 706464 
0.6 µg/L 938850 
0.8 µg/L 1454210 
0.9 µg/L 1689112 
 
Table 1: Permethrin area 
10mg*V= 0.3µg/L*1000µL V=30µL 
30µL have been taken from permethrin solution of 10mg/L and hexane was added  
10mg*V= 0.4µg/L*1000µL V=40µL 
40µL have been taken from permethrin solution of 10mg/L and hexane was added 
until 1mL. 
10mg*V= 0.6µg/L*1000µL V=60µL 
60µL have been taken from permethrin solution of 10mg/L and hexane was added 
until 1mL. 
10mg*V= 0.8µg/L*1000µL V=80µL 
80µL has been taken from permethrin solution of 10mg/L and hexane was added 
until 1mL. 
10mg*V= 0.9µg/L*1000µL V=90µL 
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90µL has been taken from permethrin solution of 10mg/L and hexane was added 
until 1mL. 
Calculations 3-PBA solutions: 
In 5mL of ACN 10mg of 3-PBA were added. 
• 3-PBA solution1 = 10000µg/ 5*10^-3L= 2000mg/L 
• 3-PBA solution 2= 2000mg/L*V=10mg/L*10mL 
V=0.05mL 
0.05mL was taken from the 3-PBA solution of 2000mg/L. Then acetonitrile was 
added until 10mL. 
• 3-PBA solution 3= 10mg/L*V=0.05mg/L*10mL 
V=0.05mL 
0.05mL was taken from the 3-PBA solution of 10mg/L. Then acetonitrile was added 
until 10mL. 
• 3-PBA solution 4= 10mg/L*V=50µg/L*10mL 
V=0.05mL 
0.05mL was taken from the 3-PBA solution of 10mg/L. Then acetonitrile was added 
until 10mL. 
• 3-PBA solution 5= 50µg/L*V=2µg/L*10mL 
V=0.4mL 
0.4mL was taken from the 3-PBA solution of 50µg/L. Then acetonitrile was added 
until 10mL. 
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In 5mL of ACN 10mg of 2-PBA were added. 
• 2-PBA solution1 = 10000µg/ 5*10^-3L= 2000mg/L 
• 2-PBA solution 2= 2000mg/L*V=10mg/L*10mL 
V=0.05mL 
0.05mL was taken from the 3-PBA solution of 2000mg/L. Then acetonitrile was 
added until 10mL. 
• 2-PBA solution 3= 10000µg/L*V=50µg/L*10mL 
V=0.05mL 
0.05mL was taken from the 2-PBA solution of 10mg/L. Then acetonitrile was added 
until 10mL. 
 
For 3PBA and 2PBA calibration curves were prepared: 
Concentrations 3PBA: 0.01µg/L, 0.05µg/L, 0.1µg/L, 0.3µg/L, 0.5µg/L, 1µg/L, 1.5µ/L 
 
Concentration 3-
PBA 
Area 3-PBA 
0.01 µg/L 13744 
0.05 µg/L 19729.67 
0.1 µg/L 22358.33 
0.3 µg/L 59872.5 
0.5 µg/L 85899 
1 µg/L 126342 
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1.5 µg/L 182345.7 
 
Table 2: 3-PBA area 
2µg/L*V= 0.01µg/L*5µL V=25µL 
2µg/L*V= 0.05µg/L*5µL V=125µL 
2µg/L*V= 0.1µg/L*5µL V=250µL 
2µg/L*V= 0.3µg/L*5µL V=750µL 
2µg/L*V= 0.5µg/L*5µL V=1.25mL 
2µg/L*V= 1µg/L*5µL V=2.5mL 
2µg/L*V= 1.5µg/L*5µL V=3.75mL 
Calculation concentration of permethrin in brains of rats sacrificed after 24h: 
 Area  
Sample 1 25187,05 
Sample 2 28025,5 
Sample 3 28694,2 
Sample 4 30233,4 
 
Equation calibration curve permethrin: y=2*10^6 – 195546 
Sample 1 
(25187, 05+195546)/2*10^6=0, 11 µg/L 
Sample 2 
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(28025, 5+195546)/2*10^6=0, 11 µg/L 
Sample 3 
(28694, 2+195546)/2*10^6=0, 11 µg/L 
Sample 4 
(30233, 4+195546)/2*10^6=0, 11 µg/L 
Average samples: (0, 11+ 0, 11+ 0, 11+ 0, 11) = 0, 11 µg/L 
Calculation concentration of permethrin in brains of rats sacrificed after 14 days: 
 Area  
Sample 1 5109745 
Sample 2 2629519 
Sample 3 658153,5 
 
Sample 1 
(5109745+195546)/2*10^6=2, 65 µg/L 
Sample 2 
(2629519+195546)/2*10^6=1, 41 µg/L 
Sample 3 
(658153, 5+195546)/2*10^6=0, 42 µg/L 
Average samples: (2, 65+1, 41+0, 42)/3= 1, 49µg/L  
Calculation concentration of 3-PBA in brains of rats sacrificed after 24h: 
 Area  
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Sample 1 345170,7 
Sample 2 429439,5 
Sample 3 442287 
Sample 4  69046 
Equation calibration curve 3-PBA: y=111977x + 17550 
Sample 1 
(345170, 7- 17550)/ 111977 = 2, 92 µg/L 
Sample 2 
(429439, 5 – 17550) / 111977 = 3, 67 µg/L 
Sample 3 
(442287 – 17550) / 111977 = 3, 79 µg/L 
Sample 4 
0 µg/L 
Average simples: (2, 92+ 3,67+ 3,79+ 0)/4 = 2,59 µg/L 
 
Calculation concentration of 3-PBA in brains of rats sacrificated after 14days: 
 Area 
Sample 1 59368 
Sample 2 115699,3 
Sample 3 103765,3 
 
Sample 1  
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 0 µg/L 
Sample 2 
0 µg/L 
Sample 3 
0 µg/L  
Average simples: 0 µg/L  
Calculation of 3-PBA in urines of rats sacrificed after 24h: 
 Area  
Sample 1 123369516 
Sample 2 181787279 
Sample 3 200621820 
Sample 4 358380967 
Sample 5 113235427 
Sample 6 162789863 
 
Sample 1 
(123369516-17550)/111977= 1101.58 µg/L 
Sample 2 
(181787279-17550)/111977= 1623.28 µg/L 
Sample 3 
(200621820-17550)/111977= 1791.48 µg/L 
Sample 4 
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(358380967-17550)/111977= 3200.33 µg/L 
Sample 5 
(113235427-17550)/111977= 1011.08 µg/L 
Sample 6 
(162789863-17550)/111977= 1453.62 µg/L 
 
Average samples: (1101.58+1623.28+1791.48+3200.33+1011.08+1453.62)/6= 
1681.9µg 
 
Calculation of 3-PBA in urines of rats sacrificed after 14days: 
 Area 
Sample 1 18628900 
Sample 2 1968870 
Sample 3 1656695 
Sample 4 6669439 
Sample 5 3077413 
 
Sample 1 
(18628900-17550)/111977= 166.21 µg/L 
Sample 2 
0 µg/L 
Sample 3 
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0 µg/L 
Sample 4 
0 µg/L 
Sample 5 
0 µg/L 
Average samples: (166.21+0+0+0+0)/5= 33.42 µg/L 
 
 
 
